Achieving end-to-end continuous bioprocessing without introducing surges and pooling remains a goal for biomanufacturers. As they transition from vat to hybrid or continuous processing, ...

New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

New, more flexible and affordable benchtop system is designed for the flexibility and customizability demanded by preclinical research, process development, and translational applicationsRIO RANCHO, N ...

With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...

By Nancy Lapid July 9 (Reuters) - A biotechnology company says it has successfully used its 3D bioprinter aboard the ...

DelveInsight's Biopharmaceutical Processing Equipment & Consumables Market Insights report provides the current and forecast market analysis, individual leading biopharmaceutical processing equipment ...

The biopharmaceutical processing equipment & consumables market is witnessing robust growth, driven by the rising production of biologics, biosimilars, vaccines, and advanced cell and gene therapies.

Cellular and gene therapies have become established treatment options for hematological diseases, including rare and aggressive neoplasms. The clinical ...

Section 232 introduces a staged tariff regime: 100% default for patented drugs/APIs/KSMs, reduced 20% with approved onshoring plans, and temporary 0% if paired with MFN pricing until 2029. Deadlines ...